Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase 3 1Phase 1/2 1

Status

Active not recruiting 2Terminated 1Recruiting 1

Sponsor Class

NIH 7NETWORK 7OTHER 4INDUSTRY 1

Study Type

Interventional 4

Sponsor

Cancer Type

Lymphoid 4Other hematologic neoplasm 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 54Leukemia 30Lymphoma, Extranodal NK-T-Cell 21Lymphoma 9Recurrence 7Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 6Lymphohistiocytosis, Hemophagocytic 5Burkitt Lymphoma 4Leukemia, T-Cell 3Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 2Neoplasm, Residual 2Lymphoma, Non-Hodgkin 2Leukemia, Biphenotypic, Acute 2Epstein-Barr Virus Infections 2Neoplasms, Plasma Cell 1Neoplasms 1Multiple Myeloma 1Mucositis 1Lymphoma, T-Cell 1Leukemia, Myeloid, Acute 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Leukemia, B-Cell 1Hodgkin Disease 1Hematologic Neoplasms 1Drug-Related Side Effects and Adverse Reactions 1Blast Crisis 1

Interventions

Cyclophosphamide 160Rituximab 82Peripheral Blood Stem Cell Transplantation 78fludarabine phosphate 75Etoposide 69Filgrastim 67Methotrexate 59Cytarabine 58Vincristine 50Mycophenolic Acid 50Whole-Body Irradiation 48Radiotherapy 43Cyclosporine 43Busulfan 42Tacrolimus 40Melphalan 39Dexamethasone 37Prednisone 36Doxorubicin 36Antilymphocyte Serum 36fludarabine 31blinatumomab 27Methylprednisolone 24Granulocyte Colony-Stimulating Factor 22Carmustine 22Cord Blood Stem Cell Transplantation 21Calcium Dobesilate 18CT-P10 18Inotuzumab Ozogamicin 16sargramostim 15

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
OTHER × Burkitt Lymphoma × pegaspargase × Clear all
NCT03150693 2026-06-02

Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia

Alliance for Clinical Trials in Oncology

Phase 3 Recruiting
310 enrolled
Lymphoid

Burkitt Lymphoma

NCT05157971 2026-05-28

Venetoclax and a Pediatric-Inspired Regimen for the Treatment of Newly Diagnosed B Cell Acute Lymphoblastic Leukemia

City of Hope Medical Center

Phase 1 Active not recruiting
24 enrolled
Lymphoid

Burkitt Lymphoma

NCT03808610 2026-05-13

Low-Intensity Chemotherapy and Venetoclax in Treating Patients With Relapsed or Refractory B- or T-Cell Acute Lymphoblastic Leukemia

M.D. Anderson Cancer Center

Phase 1/2 Terminated
53 enrolled
LymphoidOther hematologic neoplasm

Burkitt Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

NCT03962465 2023-08-22

ALL-001

University of Virginia

Phase 1 Active not recruiting
36 enrolled
Lymphoid

Burkitt Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡